There is evidence in the literature that plasma MCP-1 levels in patients with acute coronary syndrome are significantly higher than in patients with stable coronary artery disease and significantly higher than in healthy subjects [27,28,29]. This evidence concerns the gene CCL2 and acute coronary syndrome.